116 related articles for article (PubMed ID: 34825752)
1. Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine.
Koutlas IG; Camara R; Argyris PP; Davis MDP; Miller DD
Oral Dis; 2022 Nov; 28 Suppl 2():2612-2613. PubMed ID: 34825752
[No Abstract] [Full Text] [Related]
2. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
Akoglu G
Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
[TBL] [Abstract][Full Text] [Related]
3. Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al.
Falcinelli F; Lamberti A; Cota C; Rubegni P; Cinotti E
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e976-e978. PubMed ID: 35789506
[No Abstract] [Full Text] [Related]
4. Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine.
Punjwani S; Khanna P; Jani C; Waston J; Behlau I
Am J Ther; 2022 May-Jun 01; 29(3):e358-e361. PubMed ID: 35533327
[No Abstract] [Full Text] [Related]
5. Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.
Martora F; Fabbrocini G; Nappa P; Megna M
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e750-e751. PubMed ID: 35679165
[No Abstract] [Full Text] [Related]
6. Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2.
Davila-Fernandez G; Sanchez-Moreno GV; Madrigal-Burgaleta R
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2166-2168.e1. PubMed ID: 35513307
[No Abstract] [Full Text] [Related]
7. Skin reactions to mRNA-1273 SARS-CoV-2 vaccine.
Wang RL; Huang LY; Yang CC; Hsieh CY; Wu KA; Chan JS; Wu KL; Shyu HY; Kao YH; Shang ST; Hsiao PJ
QJM; 2022 Dec; 115(12):878. PubMed ID: 35038738
[No Abstract] [Full Text] [Related]
8. Response to: Skin reactions to mRNA-1273 SARS-CoV-2 vaccine.
Kano Y; Kasami S; Murata K; Kato M
QJM; 2022 Dec; 115(12):879. PubMed ID: 35038737
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccines surveillance in France: a global response to a major national challenge.
Benkebil M; Gautier S; Gras-Champel V; Massy N; Micallef J; Valnet Rabier MB
Anaesth Crit Care Pain Med; 2021 Jun; 40(3):100866. PubMed ID: 33895471
[No Abstract] [Full Text] [Related]
10. Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis.
Scheuermeyer FX; Yoo J; Greene M; O'Donnell S
CJEM; 2022 Mar; 24(2):230-232. PubMed ID: 35038138
[No Abstract] [Full Text] [Related]
11. Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine.
Briani C; Ferrari S; Tagliapietra M; Trentin L; Visentin A
J Neurol; 2023 Mar; 270(3):1207-1210. PubMed ID: 36355184
[No Abstract] [Full Text] [Related]
12. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
Wang M; Wen W; Zhou M; Wang C; Feng ZH
Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
[No Abstract] [Full Text] [Related]
13. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
Masuccio FG; Comi C; Solaro C
Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
[No Abstract] [Full Text] [Related]
14. De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.
Saffarian Z; Samii R; Ghanadan A; Vahidnezhad H
Dermatol Ther; 2022 Jun; 35(6):e15448. PubMed ID: 35289040
[No Abstract] [Full Text] [Related]
15. A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination.
Ligrone L; Lembo S; Cillo F; Spennato S; Fabbrocini G; Raimondo A
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1369-e1371. PubMed ID: 37561928
[No Abstract] [Full Text] [Related]
16. Erythema nodosum after Moderna mRNA-1273 COVID-19 vaccine.
Teymour S; Ahram A; Blackwell T; Bhate C; Cohen PJ; Whitworth JM
Dermatol Ther; 2022 Apr; 35(4):e15302. PubMed ID: 34984777
[No Abstract] [Full Text] [Related]
17. Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination.
Hung WK; Chi CC
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e407-e409. PubMed ID: 35073431
[No Abstract] [Full Text] [Related]
18. Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid.
Solimani F; Mesas-Fernández A; Bodner E; Carevic-Neri M; Hasheminasab M; Jakovljevicova T; Philipp A; Nast A; Worm M; Hilke FJ; Meier K; Ghoreschi K
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e695-e697. PubMed ID: 36786360
[No Abstract] [Full Text] [Related]
19. Pemphigus vulgaris with advanced hypopharyngeal and gastric cancer following SARS-CoV-2 vaccination.
Norimatsu Y; Yoshizaki A; Yamada T; Akiyama Y; Toyama S; Sato S
J Dermatol; 2023 Feb; 50(2):e74-e75. PubMed ID: 35906790
[No Abstract] [Full Text] [Related]
20. Pemphigus foliaceus triggered after inactivated SARS-CoV-2 vaccine: Coincidence or causal link?
Alami S; Benzekri L; Senouci K; Meziane M
Dermatol Ther; 2022 Oct; 35(10):e15775. PubMed ID: 35976680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
